Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
05:00pm, Tuesday, 23'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ:MRNA). Such investors are advised to cont
Carlyle Group co-founder David Rubenstein joining Moderna's board
10:19am, Tuesday, 23'rd Jul 2024
Moderna Inc. said Tuesday that Bob Langer, one of its founders, will retire from the board and that Carlyle Group Inc. co-founder David Rubenstein will become a director on Aug. 5.
Moderna co-founder Robert Langer to step down from vaccine maker's board
08:17am, Tuesday, 23'rd Jul 2024
Robert Langer, co-founder and a key figure behind Moderna's scientific success, will step down from the vaccine maker's board on Aug. 5, the company said on Tuesday.
David Rubenstein Joins Moderna's Board of Directors
07:00am, Tuesday, 23'rd Jul 2024
Co-Founder and Co-Chairman of The Carlyle Group brings multi-industry investor experience and global policy expertise, replacing retiring director Stephen Berenson Co-founder and director Robert Lange
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Monday, 22'nd Jul 2024
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
04:12pm, Saturday, 20'th Jul 2024
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. (“Moderna” or the “Company”) (NASDAQ: MRNA). Such investors are advis
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
06:26pm, Thursday, 18'th Jul 2024
NEW YORK , July 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to cont
3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition
07:00am, Thursday, 18'th Jul 2024
The biotech sector possesses a significant predicted Compounding Annual Growth Rate (CAGR) of 14% between 2023 to 2032. But the risks certainly match the rewards.
3 Biotech Stocks to Buy in Case of Another Pandemic
01:33pm, Tuesday, 16'th Jul 2024
While the last two major global pandemics were more than 100 years apart, a few international agencies warn of the increased potential for more frequent pandemics. This is admittedly a concerning and
Moderna (MRNA) Stock Rises 22% YTD: Time to Buy the Stock?
11:16am, Tuesday, 16'th Jul 2024
Shares of Moderna (MRNA) continue to soar thanks to the encouraging development of its non-COVID pipeline. The company's potential product launches over the next few years make it worth looking at.
2 Growth Stocks Down 25% to Buy Right Now
05:10am, Monday, 15'th Jul 2024
Starbucks is struggling in the short term but has a clear path to improved results. Moderna can expect increased revenue after a new vaccine it developed received FDA approval.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
12:00pm, Sunday, 14'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ:MRNA). Such investors are advised to cont
Is Moderna Stock a Buy?
06:27am, Sunday, 14'th Jul 2024
Moderna's performance slowed as the pandemic's worst effects began to wane. The company is notching important clinical and regulatory wins.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
09:52am, Friday, 12'th Jul 2024
NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. (“Moderna” or the “Company”) (NASDAQ: MRNA). Such investors are advis
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
06:12pm, Wednesday, 10'th Jul 2024
NEW YORK , July 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to con
